Medtech Talk

Rick Randall’s initial foray into leading a Medtech company represented a bit of a fairy tale. But his next chapter – starting and leading spine company Trans1 – serves as a bit of a Medtech nightmare.

Rick Randall landed his first job in Medtech on a bet. Today, he’s one of the sector’s most experienced CEOs. In the first part of a two-part interview with Medtech Talk, Randall, the CEO of OMNIlife science, the robotic-assisted surgery company, explains how serendipity has helped guide his path into the sector.

Serial innovator Mark Blumenkranz, MD, who last year moved into an emeritus position at Stanford, shares his enthusiasm and concerns for the future of innovation in the US.

For more than a decade, Lisa Suennen, Senior Managing Director, healthcare at GE Ventures and Managing Partner at Venture Valkyrie, LLC, has blogged and opined on the healthcare industry. In this podcast she reveals what first led her to speak up and shares how Medtech execs can find their own voices. She also talks about CSweetner.org, a not-for-profit she created to help women executives rise to the C-suite.

Nim Shah left Domain Associates to take on the chief business officer role at hot Start-Up Fractyl Laboratories. Hear why he made the change, what he feels went wrong for Medtech, and what’s next for Fractyl.

Ryan Egeland, senior director, business development & licensing at Medtronic, is searching for tech and start-ups that bolster the Medtech giant’s surgical innovations group.

Kirk Nielsen’s path to Versant passed through thoughts of medical school, a short stint in the NHL, and a span at Medtronic. Today, Nielsen represents the global VC’s interests in Medtech, serving as part of a new generation of partners taking over from the VC giant’s founders.

Trod Founder and CEO Andre Faure tells the tale of Trod, a low-capital-burning start-up focused on introducing a next-generation of ablation tools to treat the prostate and other soft tissue.

You can’t be involved in as many successful start-ups as Tom Ressemann and not walk away with great lessons and valuable experiences. The former Entellus founder and CEO examines the wins and challenges and explains how they’re guiding his hand at Amphora Medical.

Zeshan Muhammedi thinks he and his co-founders of FundRx have identified some “misalignments” in funding Medtechs. The solution may be FundRx, a new breed of venture capital firm bringing LPs, KOLs, and entrepreneurs on the same page.